Publisher's Synopsis
Research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as "cosmeceuticals" in the United States, "quasi-drugs" in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. This title examines the concept of reconstructed human epidermis equivalents and its characterization and application in cutaneous pharmatoxiocology.
